(CNSP) - FDA

(CNSP) – FDA

Dec 18, 2023 08:40 AM CNS Pharmaceuticals (CNSP) Announces Successful Interim Analysis of Efficacy and Safety Data in Study of Berubicin
Nov 22, 2023 09:08 AM CNS Pharmaceuticals (CNSP) Presents Updated Safety Data from Ongoing Potentially Pivotal Study Evaluating Berubicin in Advance of the Pre-Planned Interim Analysis of Efficacy
Aug 14, 2023 08:39 AM
Aug 3, 2023 08:04 AM
Jan 12, 2023 08:45 AM
Dec 8, 2022 09:11 AM
Jun 23, 2022 08:35 AM
Jun 8, 2022 08:35 AM
Apr 28, 2022 08:36 AM
Apr 6, 2022 08:35 AM
Apr 5, 2022 08:36 AM
Dec 2, 2021 08:35 AM
Jun 29, 2021 08:36 AM
Dec 17, 2020 09:03 AM
Nov 17, 2020 08:02 AM
Nov 9, 2020 08:14 AM
Aug 25, 2020 08:48 AM
Jun 11, 2020 08:03 AM
Jun 10, 2020 10:22 AM
Mar 4, 2020 06:10 AM
Dec 10, 2019 08:03 AM
Nov 21, 2019 08:36 AM